Svas Biosana S.p.A. (BIT:SVS)
Italy flag Italy · Delayed Price · Currency is EUR
8.50
+0.18 (2.16%)
At close: Dec 3, 2025

Svas Biosana Revenue

Svas Biosana had revenue of 71.70M EUR in the half year ending June 30, 2025, with 26.06% growth. This brings the company's revenue in the last twelve months to 134.95M, up 9.02% year-over-year. In the year 2024, Svas Biosana had annual revenue of 122.29M with 0.54% growth.

Revenue (ttm)
134.95M
Revenue Growth
+9.02%
P/S Ratio
0.33
Revenue / Employee
385.58K
Employees
327
Market Cap
44.53M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024122.29M656.90K0.54%
Dec 31, 2023121.63M22.12M22.22%
Dec 31, 202299.51M17.52M21.37%
Dec 31, 202181.99M4.72M6.11%
Dec 31, 202077.27M-23.22M-23.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Recordati Industria Chimica e Farmaceutica 2.55B
DiaSorin 1.21B
Amplifon 2.41B
EL.En. 580.41M
Philogen 84.66M
Safilo Group 998.89M
Pharmanutra 127.15M
GPI S.p.A. 531.42M
Revenue Rankings